Synerkine Pharma today announced the appointment of industry veteran Anders Ekblom, MD, PhD, DDS as a new Member of its Board of Directors. The appointment adds a wealth of pharmaceutical industry and drug development expertise to Synerkine Pharma’s board.
Synerkine Pharma appoints Industry Veteran Anders Ekblom to its Board of Directors
Previous
Previous
Synerkine Pharma and NorthX Biologics sign manufacturing alliance
Next
Next